BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6782550)

  • 1. [Liver toxicity of androgen therapy in aplastic anemia].
    Pecking A; Lejolly JM; Najean Y
    Nouv Rev Fr Hematol (1978); 1980; 22(3):257-65. PubMed ID: 6782550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy of aplastic anaemia--a prospective study of 352 cases.
    Scand J Haematol; 1979 Apr; 22(4):343-56. PubMed ID: 472658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.
    Velazquez I; Alter BP
    Am J Hematol; 2004 Nov; 77(3):257-67. PubMed ID: 15495253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and evolution of acquired aplastic anemia in childhood. A prospective analysis of 48 androgen-treated cases.
    Najean Y; Girot R; Baumelou E
    Am J Pediatr Hematol Oncol; 1982; 4(3):273-83. PubMed ID: 6756191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen therapy in aplastic anaemia: a comparative study of high and low-doses and of 4 different androgens. French Cooperative Group for the Study of Aplastic and Refractory Anemias.
    Scand J Haematol; 1986 Apr; 36(4):346-52. PubMed ID: 2872720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of aplastic anemia with cyclosporine, prednisolone and androgens (primary results apropos of 10 cases].
    Frikha M; Sahnoun Z; Kaabachi S; Elloumi M; Gargouri J; Dammak J; Zeghal KM; Souissi T
    Therapie; 1996; 51(6):627-9. PubMed ID: 9163998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
    Itterbeek P; Vandenberghe P; Nevens F; Fevery J; Aerts R; Yap SH; Demuynck H; Fourneau I; Koshiba T; Emonds MP; Roskams T; Boogaerts M; Pirenne J
    Transpl Int; 2002 Mar; 15(2-3):117-23. PubMed ID: 11935168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of Fanconi's disease and hepatic tumor in a patient undergoing long-term androgen treatment].
    Corberand J; Pris J; Dutau G; Rumeau JL; Regnier C
    Arch Fr Pediatr; 1975 Mar; 32(3):275-863. PubMed ID: 1225249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of aplastic anemia: a prospective multicenter study.
    Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
    Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens.
    Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F
    Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophy and hyperplasia of islets of Langerhans associated with androgen therapy.
    Novak R; Wilimas J; Johnson W
    Arch Pathol Lab Med; 1979 Aug; 103(9):483-5. PubMed ID: 380511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloproliferative disorder and hepatocellular adenoma following androgen treatment of a patient with aplastic anemia (author's transl)].
    Tsunematsu Y; Sasaki M; Koide T; Shimizu K
    Rinsho Ketsueki; 1978 Dec; 19(12):1699-707. PubMed ID: 216824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Refractory anemias with partial myeloblastosis. Analysis of a protocol comprising 79 cases. 1. Clinical characteristics and evolution under androgen therapy].
    Najean Y; Pecking A; Broquet M
    Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):67-80. PubMed ID: 1065863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
    Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
    Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema: Safety of long-term stanozolol therapy.
    Sloane DE; Lee CW; Sheffer AL
    J Allergy Clin Immunol; 2007 Sep; 120(3):654-8. PubMed ID: 17765757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term survival of patients with bone marrow aplasia treated with androgen therapy. 166 cases].
    Presse Med; 1983 May; 12(22):1405-10. PubMed ID: 6222331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.